Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 3

Bortezomib (Velcade™) in the treatment of multiple myeloma

Total article views   HTML views PDF downloads Totals
9,935 Dovepress* 9,935+ 2,043 11,978
Totals 9,935 2,043 11,978
*Since 15 September 2006
+Since July 2016

View citations on Google Scholar